Teva Pharmaceuticals launched the first authorized generic in the United States in June 2024, with Hikma receiving FDA approval for both generic Victoza and generic Saxenda in December 2024
Concentration accuracy is harder than it looks The 0.9% benzyl alcohol target is a narrow window with consequences on both sides: Too little benzyl alcohol (below ~0.5%) and the bacteriostatic effect weakens significantly, allowing bacterial growth in the multi-dose vial during the 28-day use window Too much benzyl alcohol (above ~2%) and tissue toxicity becomes a concern published research has documented injection site irritation, tissue damage, and in extreme concentrations, systemic toxicity from benzyl alcohol exposure For a 30 mL batch, the target benzyl alcohol volume is 0.27 mL roughly five drops from a standard dropper
This biological reality frustrates countless Canadians who remain active well into middle age
Adhering to this protocol transforms the process from a potential liability into a reliable, repeatable scientific technique
B12 (cobalamin) is an essential water-soluble vitamin crucial for red blood cell formation, neurological function, and DNA synthesis
Vegan B12 injections skip the digestive system and deliver B12 straight into the muscle, so it enters the bloodstream more reliably